tradingkey.logo

Arthrosi Secures $153 Million In Series E Financing To Complete Pivotal Development Of Pozdeutinurad For The Treatment Of Gout And Tophaceous Gout

ReutersOct 8, 2025 12:23 PM

-

  • ARTHROSI SECURES $153 MILLION IN SERIES E FINANCING TO COMPLETE PIVOTAL DEVELOPMENT OF POZDEUTINURAD FOR THE TREATMENT OF GOUT AND TOPHACEOUS GOUT

  • ARTHROSI THERAPEUTICS : FINANCING LED BY PRIME EIGHT CAPITAL LIMITED, PARTICIPATION FROM CR BIOTECH,HIGHLIGHT CAPITAL, OTHERS

Further company coverage: [ ]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI